Koers Argos Therapeutics Inc Nasdaq
Aandelen
US0402212023
Farmaceutische producten
Omzet 2016 | 945K 879K | Omzet 2017 | 1,9 mln. 1,77 mln. | Marktkapitalisatie | 13,18 mln. 12,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -53 mln. -49,25 mln. | Nettowinst (verlies) 2017 | -40 mln. -37,17 mln. | EV/omzet 2016 | 200 x |
Nettoliquiditeiten 2016 | 13,11 mln. 12,18 mln. | Nettoschuld 2017 | 4,27 mln. 3,97 mln. | EV/omzet 2017 | 9,19 x |
K/w-verhouding 2016 |
-2,96
x | K/w-verhouding 2017 |
-0,22
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 88,73% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,79% | 88,14 mld. | |
+1,45% | 40,51 mld. | |
-15,94% | 31,67 mld. | |
+52,66% | 24,62 mld. | |
-14,50% | 15,65 mld. | |
-14,38% | 12,07 mld. | |
-9,12% | 11,97 mld. | |
-42,56% | 11,61 mld. | |
+4,87% | 8,81 mld. |